GSDME and gastric cancer: In this study, we found that ALKBH4 inhibited the expression of GSDME in gastric cancer, thereby reducing 5-FU-induced pyroptosis, eventually leading to reduced sensitivity of gastric cancer cells to 5-FU treatment and promoting gastric cancer progression.